Risk of sudden unexpected death in epilepsy (SUDEP) with lamotrigine and other sodium channel‐modulating antiseizure medications

OBJECTIVE: In vitro data prompted U.S Food and Drug Administration warnings that lamotrigine, a common sodium channel modulating anti‐seizure medication (NaM‐ASM), could increase the risk of sudden death in patients with structural or ischaemic cardiac disease, however, its implications for Sudden U...

Descripción completa

Detalles Bibliográficos
Autores principales: Nightscales, Russell, Barnard, Sarah, Laze, Juliana, Chen, Zhibin, Tao, Gerard, Auvrez, Clarissa, Sivathamboo, Shobi, Cook, Mark J., Kwan, Patrick, Friedman, Daniel, Berkovic, Samuel F., D'Souza, Wendyl, Perucca, Piero, Devinsky, Orrin, O'Brien, Terence J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235563/
https://www.ncbi.nlm.nih.gov/pubmed/36648376
http://dx.doi.org/10.1002/epi4.12693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235563/
https://www.ncbi.nlm.nih.gov/pubmed/36648376
http://dx.doi.org/10.1002/epi4.12693

Ejemplares similares